The diagnostic process of women affected by breast cancer on a hereditary basis involves a first-level analysis of BRCA1 and BRCA2 genes and, if negative and clinically indicated, a second-level analysis of other cancer genes, including MUTYH. This evidence concerns the gene MUTYH and breast cancer.